ARCA biopharma Inc. is a biopharmaceutical company whose focus is developing genetically-targeted therapies for cardiovascular diseases.


Updates from The Motley Fool

Latest updates on ARCA Biopharma from Fool.com.

There is no available coverage of ARCA Biopharma at this time.



Stock Performance

View Interactive ABIO Charts
Sponsored by

Key Data Points

Primary metrics and data points about ARCA Biopharma.
Current Price: $2.45
Prev Close: $2.45
Open: $2.40
Bid: $2.40
Ask: $2.50
Day's Range: $2.40 - $2.45
52wk Range: $2.15 - $4.35
Volume: 6,589
Avg Vol 36,949
Market Cap: $22M
P/E (ttm): -1.35
EPS (ttm): ($1.81)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ARCA Biopharma.
CAPS Rating 1 out of 5
 
25 Outperform
22 Underperform
CAPS All Stars
 
5 Outperform
12 Underperform

How do you think ARCA Biopharma will perform against the market?



You pick for ARCA Biopharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael R. Bristow, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ARCA Biopharma.

ARCA biopharma Inc. is a biopharmaceutical company whose focus is developing genetically-targeted therapies for cardiovascular diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers